Epigenetic alterations of TGFβ and its main canonical signaling mediators in the context of cardiac fibrosis

J Mol Cell Cardiol. 2021 Oct:159:38-47. doi: 10.1016/j.yjmcc.2021.06.003. Epub 2021 Jun 10.

Abstract

Cardiac fibrosis is a pathological process that presents a continuous overproduction of extracellular matrix (ECM) components in the myocardium, which negatively influences the progression of many cardiac diseases. Transforming growth factor β (TGFβ) is the main ligand that triggers the production of pro-fibrotic ECM proteins. In the cardiac fibrotic process, TGFβ and its canonical signaling mediators are tightly regulated at different levels as well as epigenetically. Cardiac fibroblasts are one of the most important TGFβ target cells activated after cardiac injury. TGFβ-driven fibroblast activation is subject to epigenetic modulation and contributes to the progression of cardiac fibrosis, mainly through the expression of pro-fibrotic molecules implicated in the disease. In this review, we describe epigenetic regulation related to canonical TGFβ signaling in cardiac fibroblasts.

Keywords: Epigenetic regulation; canonical TGFβ signaling; cardiac fibrosis; fibroblasts.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Epigenesis, Genetic / genetics*
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Fibrosis / genetics*
  • Heart / physiopathology*
  • Humans
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Signal Transduction / genetics*
  • Transforming Growth Factor beta / genetics*

Substances

  • Transforming Growth Factor beta